Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines (Q34264032)

1 August 2017

1 reference

title

Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines (English)

1 reference

1 August 2017

1

1 reference

1 August 2017

Locati M

2

1 reference

1 August 2017

Vecchi A

series ordinal

3

1 reference

1 August 2017

Sozzani S

series ordinal

4

1 reference

1 August 2017

Allavena P

series ordinal

5

1 reference

1 August 2017

language of work or name

1 reference

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

22

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

328-336

1 reference

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Anti-cytokine therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Viral mechanisms of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra)

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Effects of dexamethasone treatment on IL-1 receptor mRNA levels in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Selectivity release of the type II decoy IL-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Osteoprotegerin ligand: a regulator of immune responses and bone physiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Bone cancer gain without the pain

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Steering anti-cancer drugs away from the TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

A membrane-bound Fas decoy receptor expressed by human thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The chemokine system: redundancy for robust outputs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The interleukin-8-receptor family: from chemokines to malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a – b–) phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Viral exploitation and subversion of the immune system through chemokine mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

Wnt signaling and the activation of myogenesis in mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2901941-X

7 January 2021

10.1016/S1471-4906(01)01941-X

Identifiers

DOI

1 reference

1 August 2017

1 reference